Foracort Inhaler (Generic Formoterol Fumarate and Budesonide Inhaler)
clearskypharmacy
317 views
22 slides
May 05, 2022
Slide 1 of 22
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
About This Presentation
Foracort Inhaler (Generic Formoterol Fumarate and Budesonide Inhaler) is an inhaler that is used to treat asthma in adults and adolescents aged 12 years to 17 years. It is also used to treat the symptoms of Chronic Obstructive Pulmonary Disease (COPD) in adults aged 18 years and older. It contains...
Foracort Inhaler (Generic Formoterol Fumarate and Budesonide Inhaler) is an inhaler that is used to treat asthma in adults and adolescents aged 12 years to 17 years. It is also used to treat the symptoms of Chronic Obstructive Pulmonary Disease (COPD) in adults aged 18 years and older. It contains two different medicines: Budesonide belongs to a group of medicines called 'corticosteroids'. It works by reducing and preventing swelling and inflammation in the lungs. Formoterol Fumarate Dihydrate belongs to a group of medicines called 'long-acting beta2-adrenoceptor agonists' or 'bronchodilators'. It works by relaxing the muscles in the airways. This helps the patient to breathe more easily.
The dosage of Foracort Inhaler (Generic Formoterol Fumarate and
Budesonide Inhaler) is given below:
The recommended dosage Foracort Inhaler (Formoterol and Budesonide
Inhaler) for various indications is given below: The dosage varies as per
individual being treated and should be adjusted according to disease severity.
When control has been achieved, the dose should be titrated to the lowest
effective dose, which could include Foracort Inhaler used once daily.
Adults (18 Years and Older): Maintenance Therapy: Patients should be advised
to have their separate rapid acting bronchodilator available for rescue use at all
times. FORACORT-100 Inhaler: 1 to 2 inhalations, twice daily. Maximum dose is
4 inhalations, twice daily FORACORT-200 Inhaler: 1 to 2 inhalations, twice
daily. Maximum dose is 4 inhalations, twice daily FORACORT- 400 Inhaler: 1
inhalation, twice daily. Maximum dose is 2 inhalations, twice daily.
URL: https://www.clearskypharmacy.biz/generic-symbicort-foracort-by-cipla.html
The dosage of Foracort Inhaler (Generic Formoterol Fumarate and
Budesonide Inhaler) is given below:
Adolescents (12-17 Years):Maintenance Therapy: FORACORT-100 Inhaler:
1 to 2 inhalations, twice daily. FORACORT-200 Inhaler: 1 to 2 inhalations,
twice daily. FORACORT- 400 Inhaler: 1 inhalation, twice daily
Children (6-11 Years):Maintenance Therapy: FORACORT-100 Inhaler: 2
inhalations, twice daily
Single Maintenance and Reliever Therapy (For FORACORT -100 and 200
Inhaler only): Patients take a daily maintenance dose of Foracort Inhaler
and in combination take Foracort Inhaler as needed in response to
symptoms. Patients should be advised to always have Foracort Inhaler
available for rescue use.
URL: https://www.clearskypharmacy.biz/generic-symbicort-foracort-by-cipla.html
The dosage of Foracort Inhaler (Generic Formoterol Fumarate and
Budesonide Inhaler) is given below:
Single Maintenance and Reliever Therapy (For FORACORT -100 and 200 Inhaler
only): Adults (18 years and older): The recommended maintenance dosage is 2
inhalations per day as maintenance therapy (either one inhalation twice daily, or
two inhalations in either the morning or the evening). Patients should take 1
additional inhalation as needed in response to symptoms. In case symptoms persist
after a few minutes, an additional inhalation should be taken. Not more than 6
inhalations should be taken on any single occasion.
COPD (Chronic Obstructive Pulmonary Disease) FORACORT-200 Inhaler: The
recommended dosage is 2 inhalations, twice daily
URL: https://www.clearskypharmacy.biz/generic-symbicort-foracort-by-cipla.html
Foracort Inhaler (Generic Formoterol Fumarate
and Budesonide Inhaler) have to be stored at
controlled room temperature i.e. from 20°C to
25°C (68°F to 77°F) with excursions permitted
between 15° to 30°C (59° to 86°F).
Keep this as well as all other medicines away
from children and pets.
URL: https://www.clearskypharmacy.biz/generic-symbicort-foracort-by-cipla.html
Asthma-related death: Long-acting beta2-adrenergic agonists like Foracort Inhaler
increase the risk. Prescribe only for recommended patient populations.
Deterioration of disease and acute episodes: Do not start therapy in acutely
deteriorating asthma or to treat acute symptoms.
Use with additional long-acting beta2-agonist: Do not use in combination with
additional long-acting beta2-agonist because of risk of overdose.
Localized infections: Candida albicans infection of the mouth and throat could
occur. Monitor patients periodically for signs of adverse effects on the oral cavity.
Advise patients to rinse the mouth following inhalation.
Pneumonia: Increased risk in patients with COPD. Monitor patients for signs and
symptoms of pneumonia and other potential lung infections.
Immunosuppression: Potential worsening of infections (e.g., existing tuberculosis,
fungal, bacterial, viral, or parasitic infection; or ocular herpes simplex). Use with
caution in patients with these infections.
More serious or even fatal course of chickenpox or measles can occur in
susceptible patients.
Transferring patients from systemic corticosteroids: Risk of impaired adrenal
function when transferring from oral steroids. Taper patients slowly from
systemic corticosteroids if transferring to Foracort Inhaler.
Hypercorticism and adrenal suppression: May occur with very high dosages or at
the regular dosage in susceptible individuals. If such changes occur, discontinue
Foracort Inhaler slowly.
Strong cytochrome P450 3A4 inhibitors (e.g., ritonavir): Risk of increased
systemic corticosteroid effects. Exercise caution when used with Foracort Inhaler.
Paradoxical bronchospasm: Discontinue using this medicine and institute
alternative therapy if paradoxical bronchospasm occurs.
Patients with cardiovascular or central nervous system disorders: Use with
caution because of beta-adrenergic stimulation.
Decreases in bone mineral density: Assess bone mineral density
initially and periodically thereafter.
Effects on growth: Monitor growth of pediatric patients.
Glaucoma and cataracts: Close monitoring is warranted.
Metabolic effects: Be alert to eosinophilic conditions, hypokalemia,
and hyperglycemia.
Coexisting conditions: Use with caution in patients with convulsive
disorders, thyrotoxicosis, diabetes mellitus, and ketoacidosis.